Comparing Improvements in Biopsy Decision Making with Electrical Impedance Spectroscopy Between US and German Dermatologists

Main Article Content

Danny Zakria
Nicholas Brownstone
Milaan Shah
Joshua Burshtein
Lauren DeBusk
Angela Rosenberg
Darrell Rigel

Keywords

melanoma, dysplastic nevi, biopsy, dermoscopy, electrical impedance spectroscopy, EIS, skin cancer

Abstract

Electrical impedance spectroscopy (EIS) is a noninvasive tool that measures the electrophysical properties of pigmented lesions, generating a score to aid in the differentiation of benign and malignant lesions. This research letter compares two studies, conducted in the United States (US) and Germany, evaluating the impact of EIS on biopsy decision-making among dermatologists. Both studies used the same set of clinical and dermoscopic images along with EIS scores for 49 lesions. Findings revealed that American dermatologists had a higher rate of correct biopsy decisions for malignant melanomas (MMs) and severe dysplastic nevi (SDNs) compared to their German counterparts. However, German dermatologists showed greater accuracy in avoiding unnecessary biopsies of benign pigmented skin lesions (PSLs). The addition of both dermoscopy and EIS significantly improved biopsy decision accuracy for MMs and SDNs in both groups, with EIS further mitigating initial reductions in correct biopsy choices for benign lesions. Differences in practice patterns, training, and malpractice concerns may explain the observed variations between US and German dermatologists. These results underscore the utility of EIS as a complementary tool to dermoscopy, enhancing the accuracy of biopsy decisions and improving patient outcomes.

References

1. Cheng Z, Xiuzhen D, Feng F, Zhenyu J, Canhua X. Breast cancer detection based on multi-frequency EIS measurement. Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:4158-4160. doi:10.1109/IEMBS.2007.4353252

2. Malvehy J, Hauschild A, Curiel-Lewandrowski C, et al. Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety. Br J Dermatol. 2014;171(5):1099-1107. doi:10.1111/bjd.13121

3. Litchman GH, Marson JW, Svoboda RM, Rigel DS. Integrating Electrical Impedance Spectroscopy into Clinical Decisions for Pigmented Skin Lesions Improves Diagnostic Accuracy: A Multitiered Study. SKIN. 2020;4(5):424-430. doi:10.25251/skin.4.5.5

4. Svoboda RM, Prado G, Mirsky RS, Rigel DS. Assessment of clinician accuracy for diagnosing melanoma on the basis of electrical impedance spectroscopy score plus morphology versus lesion morphology alone. J Am Acad Dermatol. 2019;80(1):285-287. doi:10.1016/j.jaad.2018.08.048

5. Zakria D, Brownstone N, Han J, Owji S, Dirr M, Rigel D. Electrical impedance spectroscopy significantly enhances correct biopsy choice for pigmented skin lesions beyond clinical evaluation and dermoscopy [published online ahead of print, 2022 Oct 13]. Melanoma Res. 2022;10.1097/CMR.0000000000000859. doi:10.1097/CMR.0000000000000859

6. Zakria, D., Brownstone, N., Fritz, K., Salavastru, C. and Rigel, D. 2024. Utilizing Data from Electrical Impedance Spectroscopy Significantly Improves the Decision to Biopsy Pigmented Skin Lesions Beyond Clinical Evaluation and Dermoscopy. SKIN The Journal of Cutaneous Medicine. 8, 3 (May 2024), 1515–1520. DOI:https://doi.org/10.25251/skin.8.3.5.

7. Jena AB, Seabury S, Lakdawalla D, Chandra A. Malpractice risk according to physician specialty. N Engl J Med. 2011;365(7):629-636. doi:10.1056/NEJMsa1012370

8. Birch N, Todd NV. The cost of consent: why healthcare providers must be compliant with the Montgomery principles. Bone Joint J. 2020;102-B(5):550-555. doi:10.1302/0301-620X.102B5.BJJ-2019-1759

Most read articles by the same author(s)

1 2 3 4 5 > >>